|
AXSM
|
Axsome Therapeutics, Inc.
|
0.22%
|
US
|
NASDAQ
|
|
GLPG
|
Galapagos NV
|
0.20%
|
US
|
NASDAQ
|
|
BCRX
|
BioCryst Pharmaceuticals, Inc.
|
0.20%
|
US
|
NASDAQ
|
|
VIR
|
Vir Biotechnology, Inc.
|
0.20%
|
US
|
NASDAQ
|
|
SAGE
|
Sage Therapeutics, Inc.
|
0.19%
|
US
|
NASDAQ
|
|
IRWD
|
Ironwood Pharmaceuticals, Inc.
|
0.18%
|
US
|
NASDAQ
|
|
IMCR
|
Immunocore Holdings plc
|
0.17%
|
US
|
NASDAQ
|
|
ABCL
|
AbCellera Biologics Inc.
|
0.17%
|
US
|
NASDAQ
|
|
RYTM
|
Rhythm Pharmaceuticals, Inc.
|
0.16%
|
US
|
NASDAQ
|
|
PACB
|
Pacific Biosciences of California, Inc.
|
0.16%
|
US
|
NASDAQ
|
|
KRYS
|
Krystal Biotech, Inc.
|
0.16%
|
US
|
NASDAQ
|
|
GRFS
|
Grifols, S.A.
|
0.16%
|
US
|
NASDAQ
|
|
FGEN
|
FibroGen, Inc
|
0.16%
|
US
|
NASDAQ
|
|
OLK
|
Olink Holding AB
|
0.16%
|
US
|
NASDAQ
|
|
XNCR
|
Xencor, Inc.
|
0.15%
|
US
|
NASDAQ
|
|
VCYT
|
Veracyte, Inc.
|
0.15%
|
US
|
NASDAQ
|
|
ARVN
|
Arvinas, Inc.
|
0.15%
|
US
|
NASDAQ
|
|
AKRO
|
Akero Therapeutics, Inc.
|
0.15%
|
US
|
NASDAQ
|
|
AGIO
|
Agios Pharmaceuticals, Inc.
|
0.15%
|
US
|
NASDAQ
|
|
VIVO
|
Meridian Bioscience Inc.
|
0.14%
|
US
|
NASDAQ
|